| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |